Q4 2018 Holdings
Filed 2019-02-14 | 12 holdings | $93.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cardlytics, Inc.(CDLX) | Common Stock | 14161W105 | $27.6K | 2,552,626 | 29.5% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $23.4K | 1,823,186 | 25.0% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $16.0K | 824,765 | 17.0% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $9.1K | 1,857,582 | 9.7% |
| T2 Biosystems, Inc. | Common Stock | 89853L104 | $5.5K | 1,841,924 | 5.9% |
| Arsanis, Inc. | Common Stock | 042873109 | $4.3K | 1,868,957 | 4.6% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $4.3K | 1,606,813 | 4.6% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $906 | 1,827,992 | 1.0% |
| Trevena, Inc. | Common Stock | 89532E109 | $883 | 2,053,540 | 0.9% |
| Pulmatrix, Inc. | Common Stock | 74584P103 | $863 | 3,594,381 | 0.9% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $565 | 1,968,606 | 0.6% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $232 | 326,243 | 0.2% |